(A) Phospholipids are deficient on LDs in seipin-knockdown cells 8 hr after initiating formation. Control or seipin knockdown cells were pulse-labeled with [14C]-oleic acid (100 μCi/μmol) for indicated times. LD fractions were purified by gradient centrifugation, and phospholipids and neutral lipids were extracted and separated by TLC. The TLC plate was exposed on an imaging screen, and the intensity of bands was quantified with FIJI. Values are integrated density normalized to protein concentration or ratio of integrated density of indicated lipid classes. n=3. **p<0.005; ***p<0.001 (B) Targeting of CCT1 to LDs is increased and earlier with seipin depletion. Control or seipin-knockdown cells were incubated with oleic acid for 1, 3, or 8 hr, and localization of endogenous CCT1 was determined by immunofluorescence. Image shows a typical result at 8 hr. Red, CCT1; green, BODIPY. Bar, 5 μm. Targeting of CCT1 to LDs was quantified and is expressed as percentage of CCT1 signal on LDs over total cellular CCT1 signal. Data are presented as box plot with Tukey’s test. n=20. *p<0.05; **p<0.01; ***p<0.001. (C) Giant LD phenotype in seipin deficiency is rescued by adding PC or choline. Control, seipin, or CCT1 knockdown cells were treated with liposomes containing PC, PE or choline for 24 hr and then incubated with oleic acid for 16 hr. LD phenotype from representative cells are shown. Bar, 10 μm. Quantification of LD size from 10 cells in each treatment is shown. Lines show mean values. Yellow box indicates giant LDs of diameter > 2.5 μm. (D) Giant LD phenotype in seipin deficiency is worsened by blocking PC synthesis and ameliorated by blocking PE synthesis. Expression of CCT1 or ECT was inhibited by respective dsRNAs, in addition to control or seipin dsRNAs. Representative LD phenotypes after 16 hr of oleic acid treatment are shown. Bar, 5 μm. Quantification of LD size from 10 cells in each treatment is shown. Lines show mean values. Yellow box indicates giant LDs of diameter > 2.5 μm.
DOI: http://dx.doi.org/10.7554/eLife.16582.029